LIFECORE BIOMEDICAL, INC. DE (LFCR) Financial Statements
LIFECORE BIOMEDICAL, INC. DE (LFCR) files with the U.S. Securities and Exchange Commission under CIK 0001005286. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2025
- Revenue
- $128.87 million
- Net Income
- -$38.72 million
- Total Assets
- $239.34 million
- Net Cash from Operations
- -$206.00 thousand
Fiscal year ended May 25, 2025. Latest periodic SEC filing: Aug 5, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for LFCR in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History